Scientific article
OA Policy
French

Prévention de l'AVC chez les patients avec une fibrillation auriculaire

Published in

Revue médicale suisse, vol. 13, no. 560, p. 911-915

Publication date

2017

Abstract

Oral anticoagulation with vitamin K antagonists (VKA) was the cornerstone of stroke prevention in atrial fibrillation (AF). This review article presents the state of the art, with regard to the treatment options developed over the past few years, the new oral anticoagulants (NOAC). A search in PubMed for relevant published studies has been performed. Dabigatran and apixaban were superior to warfarin to reduce stroke risk or systemic embolism ; dabigatran, rivaroxaban and edoxaban were non-inferior. All NOAC are globally non-inferior to warfarin for stroke prevention in non-valvular AF and they have a superior safety profile, with a reduced intracranial bleeding risk. They are now the first choice for treatment.

Citation (ISO format)

SIRIMARCO, Gaia et al. Prévention de l’AVC chez les patients avec une fibrillation auriculaire. In: Revue médicale suisse, 2017, vol. 13, n° 560, p. 911–915.

Main files (1)

Article (Published version)

Identifiers

Journal ISSN

1660-9379
631views
396downloads

Technical informations

Creation

08/11/2017 15:05:00

First validation

08/11/2017 15:05:00

Update

15/03/2023 07:40:21

Status update

15/03/2023 07:40:20

Last indexation

31/10/2024 09:10:48
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated